Laura E. Lunde
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 12
- Hematopoietic Stem Cell Transplantation 1
- Acute Myeloid Leukemia Research 1
-
- Antifungal resistance and susceptibility 1
- Co-authors
- Mary McKenney (5 shared papers)Nikhil C. Munshi (5 shared papers)Kenneth Carl Anderson (5 shared papers)Paul Gerard Guy Richardson (5 shared papers)Teru Hideshima (5 shared papers)Constantine S. Mitsiades (5 shared papers)Irene M. Ghobrial (5 shared papers)Sundar Jagannath (4 shared papers)
- Journals
- Blood (10 papers)American Journal of Hematology (1 paper)Journal of Clinical Oncology (1 paper)European Journal Of Haematology (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- United States
In The Last Decade
Laura E. Lunde
14 papers receiving 1.3k citations
Laura E. Lunde's Hit Papers
Peers
Comparison fields: 5 of 46
- Hematology 1.2k
- Internal Medicine 23
- Drug Discovery 1
- Oncology 76
- Transplantation 6
Countries citing papers authored by Laura E. Lunde
This map shows the geographic impact of Laura E. Lunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Lunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Lunde more than expected).
Fields of papers citing papers by Laura E. Lunde
This network shows the impact of papers produced by Laura E. Lunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Lunde. The network helps show where Laura E. Lunde may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura E. Lunde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma Hit paper breakdown → | 2010 | 728 |
| 2 | 2014 | 168 | |
| 3 | 2009 | 147 | |
| 4 | 2015 | 93 | |
| 5 | 2006 | 53 | |
| 6 | 2004 | 49 | |
| 7 | 2005 | 32 | |
| 8 | 2008 | 32 | |
| 9 | 2010 | 25 | |
| 10 | 2007 | 24 | |
| 11 | 2005 | 19 | |
| 12 | 2012 | 9 | |
| 13 | 2004 | 7 | |
| 14 | 2012 | 5 |
About Laura E. Lunde
Laura E. Lunde is a scholar working on Hematology, Infectious Diseases, Molecular Biology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Antifungal resistance and susceptibility (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Retinoids in leukemia and cellular processes (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (1.2k citations), Internal Medicine (23 citations), Drug Discovery (1 citation), Oncology (76 citations) and Transplantation (6 citations). Laura E. Lunde has collaborated with scholars based in United States. Frequent co-authors include Mary McKenney, Nikhil C. Munshi, Kenneth Carl Anderson, Paul Gerard Guy Richardson, Teru Hideshima, Constantine S. Mitsiades, Irene M. Ghobrial, Sundar Jagannath, Robert Knight and Amitabha Mazumder. Their work appears in journals such as Blood, American Journal of Hematology, Journal of Clinical Oncology, European Journal Of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.